We are live on
!
Find out more
VF
Virtu Financial Portfolio holdings
AUM
$3.18B
Turnover
77.45%
1-Year Est. Return
65.92%
This Fund
S&P 500
This Quarter
Est. Return
+4.12%
1 Year Est. Return
+65.92%
3 Year Est. Return
+160.27%
5 Year Est. Return
+179.96%
10 Year Est. Return
–
AUM
$2.02B
AUM Growth
+$1.3B
(+180%)
Cap. Flow
+$1.27B
Cap. Flow
% of AUM
62.76%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
2,553
New
2,160
Increased
164
Reduced
123
Closed
87
Avg Time Held Equity + Options
0.1
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$40.3M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$21M |
| 3 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$19.2M |
| 4 |
AF
Astoria Financial Corporation
AF
|
+$18.7M |
| 5 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$18.6M |
| 3 |
OKS
Oneok Partners LP
OKS
|
+$15.5M |
| 4 |
ProShares Short S&P500
SH
|
+$9.57M |
| 5 |
Invesco CurrencyShares British Pound Sterling Trust
FXB
|
+$7.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 57.39% |
| 2 | Financials | 7.24% |
| 3 | Consumer Discretionary | 7% |
| 4 | Healthcare | 6.56% |
| 5 | Technology | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2401
Inuvo
INUV
$7.58M
| $11K | ﹤0.01% |
+1,085
| New | +$11K |
2017 Q3
0 quarters
|
|
2402
Novavax
NVAX
$2.11B
| $11K | ﹤0.01% |
+504
| New | +$11.3K |
2017 Q3
0 quarters
|
|
|
BDR
2403
DELISTED
Blonder Tongue Laboratories Inc
BDR
| $11K | ﹤0.01% |
+23,404
| New | +$12.2K |
2017 Q3
0 quarters
|
|
|
LCAHW
2404
DELISTED
Landcadia Holdings, Inc. Warrant
LCAHW
| $11K | ﹤0.01% |
+14,500
| New | +$10.7K |
2017 Q3
0 quarters
|
|
2405
Cerenome
CNSY
$14.3M
| – | – |
0
| – | – |
2017 Q3
0 quarters
|
|
2406
Q/C Technologies Inc
QCLS
$4.57M
| – | – |
0
| – | – |
2017 Q3
0 quarters
|
|
2407
DELISTED
Superior Drilling Products Inc.
SDPI
| $10K | ﹤0.01% |
+12,348
| New | +$8.77K |
2017 Q3
0 quarters
|
|
2408
DELISTED
Cellectar Biosciences, Inc. Series A Warrants
CLRBZ
| $10K | ﹤0.01% |
+15,596
| New | +$9.13K |
2017 Q3
0 quarters
|
|
|
FPP
2409
DELISTED
FieldPoint Petroleum Corporation
FPP
| $10K | ﹤0.01% |
+31,369
| New | +$10.3K |
2017 Q3
0 quarters
|
|
|
RNVA
2410
DELISTED
Rennova Health, Inc.
RNVA
| $10K | ﹤0.01% |
+3,565
| New | +$15.2K |
2017 Q3
0 quarters
|
|
2411
IT Tech Packaging
ITP
$2.48M
| $9K | ﹤0.01% |
+1,101
| New | +$9.95K |
2017 Q3
0 quarters
|
|
2412
TRX Gold Corp
TRX
$347M
| $9K | ﹤0.01% |
+27,198
| New | +$11.4K |
2017 Q3
0 quarters
|
|
|
GLOWE
2413
DELISTED
GLOWPOINT INC
GLOWE
| $9K | ﹤0.01% |
+34,816
| New | +$9K |
2017 Q3
0 quarters
|
|
2414
DELISTED
ESSA Pharma
EPIX
| $8K | ﹤0.01% |
+1,432
| New | +$9.99K |
2017 Q3
0 quarters
|
|
2415
DELISTED
Golden Minerals Company
AUMN
| $8K | ﹤0.01% |
+683
| New | +$9.11K |
2017 Q3
0 quarters
|
|
|
JSYNR
2416
DELISTED
Jensyn Acquistion Corp. Rights
JSYNR
| $8K | ﹤0.01% |
+24,100
| New | +$7.64K |
2017 Q3
0 quarters
|
|
|
ARGS
2417
DELISTED
Argos Therapeutics, Inc.
ARGS
| $8K | ﹤0.01% |
+2,362
| New | +$11.3K |
2017 Q3
0 quarters
|
|
2418
LiqTech
LIQT
$12.3M
| $7K | ﹤0.01% |
+595
| New | +$6.9K |
2017 Q3
0 quarters
|
|
2419
SELLAS Life Sciences
SLS
$2.29B
| $7K | ﹤0.01% |
+13
| New | +$8.58K |
2017 Q3
0 quarters
|
|
|
CYHHZ
2420
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
| $7K | ﹤0.01% |
+645,929
| New | +$9.24K |
2017 Q3
0 quarters
|
|
2421
AIM ImmunoTech
AIM
$6.79M
| $7K | ﹤0.01% |
+5
| New | +$8.77K |
2017 Q3
0 quarters
|
|
2422
IGC Pharma
IGC
$26.3M
| $6K | ﹤0.01% |
+17,286
| New | +$6.4K |
2017 Q3
0 quarters
|
|
2423
Oragenics
OGEN
$1.97M
| $6K | ﹤0.01% |
+1
| New | +$6.61K |
2017 Q3
0 quarters
|
|
2424
Oxbridge Re Holdings Ltd Warrant
OXBRW
| $6K | ﹤0.01% |
+25,577
| New | +$10.5K |
2017 Q3
0 quarters
|
|
2425
Arcadia Biosciences
RKDA
$490K
| $6K | ﹤0.01% |
+19
| New | +$6.96K |
2017 Q3
0 quarters
|
|
Similar funds
GM
TA
CI
GIA
NSLI
Virtu Financial's Q3 2017 Portfolio in Review
As of Q3 2017, Virtu Financial held 2,553 positions worth $2.02B, up 180% from $721M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Virtu Financial deployed $1.27B of net new capital in Q3 2017, opening 2,160 new positions and adding to 164 existing holdings. Its largest new stake was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, down from 79% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $24.8M trimmed.
- Virtu Financial's largest Q3 2017 buy was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
- Virtu Financial added most to VanEck Gold Miners ETF in Q3 2017, an estimated $40.3M increase.
- Virtu Financial's biggest Q3 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $24.8M.
- Virtu Financial fully exited Oneok Partners LP in Q3 2017, selling an estimated $15.5M.
- Virtu Financial's ten largest holdings make up 17% of its $2.02B portfolio in Q3 2017.
- Virtu Financial opened 2,160 new positions and closed 87 in Q3 2017.
- Virtu Financial's portfolio value rose 180% quarter-over-quarter to $2.02B.
Based on Virtu Financial's 13F filing for Q3 2017, filed 15 Nov 2017.